According to recent research report “Digital PCR Market is poised to reach $12.4 billion by 2028, growing at a CAGR of 7.8% from 2023 to 2028. These estimations are based on comprehensive research and analysis conducted to identify industry trends in this market segment.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=174151204
qPCR reagents and consumables accounted for the largest share of Digital PCR Market
Based on products & services, the qPCR market is categorized into reagents and consumables, instruments and software & services. The qPCR reagents and consumables segment is expected to command the largest share of the qPCR products & services market. This segment includes qPCR reagents (such as supermixes, enzymes, and specific detection agents) and consumables (such as reaction tubes, needles, and vials) required during a typical qPCR analysis procedure. The sale of qPCR reagents through various approaches by prominent players (such as bundled sales of qPCR reagents for 3-5 years along with the purchase of qPCR instruments; long-term sales contracts for qPCR reagents upon device upgradation; and bundled sales of related consumables on the long-term purchase of qPCR reagents) is also a major factor driving the demand and uptake of qPCR reagents & consumables in major markets such as Europe, the US, Japan, China, and India.
Clinical application segment accounted for the largest share of Digital PCR Market
Based on application, the qPCR market is categorized into clinical applications (Infectious Disease Testing, Oncology Testing, Blood Screening, Transplant Diagnostics and Other Clinical Applications), research applications and forensic applications. The clinical applications segment is estimated to dominate the qPCR applications market. qPCR analysis has transformed significantly from a conventional DNA quantification technique into an advanced diagnostic technique used in several diagnostic applications, such as prenatal testing to identify inborn genetic defects, disease diagnosis such as early cancer detection, pathogen detection in infections (such as anthrax, malaria, herpes, hepatitis, HIV, and tuberculosis), and the identification of blood-borne diseases during a blood transfusion.
The hospitals and diagnostic centers is the largest and fastest gowing end user segment of the qPCR market
Based on end users, the qPCR market is segmented into research laboratories and academic institutes, pharmaceutical and biotechnology companies, hospitals and diagnostic centers, clinical research organizations (CROs), and forensic laboratories. The hospitals and diagnostic centers segment accounted for the largest share of the market. The hospitals and diagnostic centers segment includes in-house diagnostic and clinical research centers at hospitals, intendant diagnostic & pathology centers, and reference laboratories (that work for small hospitals, independent physicians, and community clinics). These end-users use qPCR analysis in the diagnosis of target diseases and disorders (including cancer, HIV-AIDS, genetic disorders, infectious diseases, and chronic diseases, among others).
North America accounted for the largest share of the dPCR and qPCR market
North America accounted for the largest share of the digital PCR market, followed by Europe. North America is a mature market with a high penetration of qPCR and dPCR technologies among key end users (including hospitals, diagnostic centers, research laboratories, pharmaceutical and biotechnology companies, and forensic laboratories), robust genomics research infrastructure, and strong market presence of genomic product manufacturers.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=174151204
The prominent players operating in the digital PCR market are Thermo Fisher Scientific (US), Bio-Rad Laboratories Inc. (US), and F. Hoffmann-La Roche, Ltd. (Switzerland).
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com
